Product Information
METFORMIN HCL 500 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0142 per EA under NDC 82009017410. Its NADAC has been published 42 times since Nov 5, 2025.
FDA first approved this application on Aug 28, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009017410
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203686FDA Approved
8/28/2014
TE Code
AB
On Market Since
7/18/2025
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 500 MG TABLET has been published 42 times since Nov 5, 2025, and over the history we have for it it has declined 2.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0142 per EA |
|---|---|
| All-time high | $0.0146 (Dec 10, 2025) |
| All-time low | $0.0139 (Apr 22, 2026) |
| 52-week high | $0.0146 |
| 52-week low | $0.0139 |
| Median price | $0.0140 |
| Average price | $0.0141 |
| Largest weekly change | -3.2% (Dec 17, 2025) |
| Weeks tracked | 42 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METFORMIN HCL 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 500 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0142 per EA (NDC 82009017410), effective Aug 19, 2026.
How has the price of METFORMIN HCL 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 500 MG TABLET has declined 2.6%. It has been tracked across 42 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 500 MG TABLET?
Since Nov 5, 2025, the NADAC for METFORMIN HCL 500 MG TABLET has ranged from a low of $0.0139 (Apr 22, 2026) to a high of $0.0146 (Dec 10, 2025), with a median of $0.0140 per EA.
Are there cheaper alternatives to METFORMIN HCL 500 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METFORMIN HCL 500 MG TABLET, is $0.0140 per EA — about 2% below METFORMIN HCL 500 MG TABLET.
Who manufactures METFORMIN HCL 500 MG TABLET?
METFORMIN HCL 500 MG TABLET (NDC 82009017410) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.